Cytokines signaling and IL17 Pathways - YouTube
Multimedia | Targeting IL-17 in inflammatory disease
Frontiers | Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis | Pharmacology
Paradoxical gastrointestinal effects of interleukin-17 blockers | Annals of the Rheumatic Diseases
IL-17 antibodies gain momentum | Nature Reviews Drug Discovery
Frontiers | IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications | Immunology
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies - ScienceDirect
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies - ScienceDirect
IL-23 Antagonists in the Treatment of Plaque Psoriasis - Dermatology Advisor
Shifting the focus – the primary role of IL‐23 in psoriasis and other inflammatory disorders - Gooderham - 2018 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library
The protective and pathogenic roles of IL-17 in viral infections: friend or foe? | Open Biology
New Biologics in Psoriasis: An Update on IL-23 and IL-17 Inhibitors | MDedge Dermatology
Update on IL-17 Inhibitors for Psoriasis | SpringerLink
Frontiers | The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond | Immunology
Cells | Free Full-Text | Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities | HTML
Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis | Arthritis Research & Therapy | Full Text
Bimekizumab: The First Dual Inhibitor of Interleukin (IL)-17A and IL-17F for the Treatment of Psoriatic Disease and Ankylosing Spondylitis | SpringerLink
Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis | The Journal of Immunology
Targeting of interleukin-17 in the treatment of psoriasis | CCID
Psoriatic Arthritis and New First-Line Treatment Options: Interleukin-17 Inhibitors
Interleukin-17: A potential therapeutic target in COVID-19 - Journal of Infection
IL-17 in Chronic Inflammation: From Discovery to Targeting: Trends in Molecular Medicine
Comparison of Guidelines for the Use of Interleukin-17 Inhibitors for Psoriasis in the United States, Britain, and Europe: A Critical Appraisal and Comprehensive Review – JCAD | The Journal of Clinical and
Biologics in Psoriasis: The Next Generation - Practical Dermatology
Interleukin-17 Inhibitors Therapeutic Cheat Sheet - Next Steps in Dermatology
Interleukin-17 and type 17 helper T cells in cancer management and res | ITT
